MA31062B1 - Agents tensioactifs reconstitues presentant des proprietes ameliorees. - Google Patents
Agents tensioactifs reconstitues presentant des proprietes ameliorees.Info
- Publication number
- MA31062B1 MA31062B1 MA31854A MA31854A MA31062B1 MA 31062 B1 MA31062 B1 MA 31062B1 MA 31854 A MA31854 A MA 31854A MA 31854 A MA31854 A MA 31854A MA 31062 B1 MA31062 B1 MA 31062B1
- Authority
- MA
- Morocco
- Prior art keywords
- improved properties
- reconstituted surfactants
- reconstituted
- relates
- surfactants
- Prior art date
Links
- 239000004094 surface-active agent Substances 0.000 title abstract 3
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108010007131 Pulmonary Surfactant-Associated Protein B Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Fire-Extinguishing Compositions (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06021521 | 2006-10-13 | ||
| PCT/IB2007/002841 WO2008044109A1 (en) | 2006-10-13 | 2007-09-28 | Reconstituted surfactants having improved properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA31062B1 true MA31062B1 (fr) | 2010-01-04 |
Family
ID=39079026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA31854A MA31062B1 (fr) | 2006-10-13 | 2009-05-08 | Agents tensioactifs reconstitues presentant des proprietes ameliorees. |
Country Status (35)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008011559A2 (en) | 2006-07-20 | 2008-01-24 | University Of Rochester | Synthetic lung surfactant and use thereof |
| EP1997502A1 (en) * | 2007-06-01 | 2008-12-03 | CHIESI FARMACEUTICI S.p.A. | Reconstituted surfactants having improved properties |
| US8399406B2 (en) * | 2009-06-05 | 2013-03-19 | Chiesi Farmaceutici S.P.A. | Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C) |
| CN101948526B (zh) * | 2010-09-02 | 2012-12-05 | 华东理工大学 | 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法 |
| EP3459556A1 (en) | 2012-02-09 | 2019-03-27 | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Synthetic analogs of lung surfactant protein sp-c and their use |
| US20130303726A1 (en) * | 2012-04-17 | 2013-11-14 | Chiesi Farmaceutici S.P.A. | Method for the preparation of surfactant peptides |
| EP2922868B1 (en) * | 2012-11-21 | 2017-09-27 | Chiesi Farmaceutici S.p.A. | Reconstituted pulmonary surfactants |
| US10717777B2 (en) | 2015-12-17 | 2020-07-21 | The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Synthetic lung surfactant with enhanced stability and effectiveness |
| EP3452041B1 (en) | 2016-03-07 | 2026-01-14 | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Compositions and methods for administering ppar-gamma-agonists, surfactant peptides and phospholipids |
| RU2748417C2 (ru) | 2016-08-24 | 2021-05-25 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Стабильная фармацевтическая композиция, включающая восстановленную композицию легочного сурфактанта |
| WO2021151853A1 (en) | 2020-01-28 | 2021-08-05 | Chiesi Farmaceutici S.P.A. | Polypeptides having improved properties |
| WO2022082082A2 (en) * | 2020-10-16 | 2022-04-21 | Sherwood Russ Lehrman | Lung treatment compositions |
| WO2025024609A1 (en) * | 2023-07-25 | 2025-01-30 | Biosuperior Technology, Inc. | Polypeptides for lung surfactant compositions |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2163860A1 (en) * | 1993-06-30 | 1995-01-12 | Chung C. Hsu | Method for preparing liposomes |
| IT1308180B1 (it) * | 1999-02-12 | 2001-12-07 | Chiesi Farma Spa | Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante |
| US7065342B1 (en) * | 1999-11-23 | 2006-06-20 | Gofigure, L.L.C. | System and mobile cellular telephone device for playing recorded music |
| ITMI20021058A1 (it) * | 2002-05-17 | 2003-11-17 | Chiesi Farma Spa | Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito |
| EP1481665A1 (en) * | 2003-05-30 | 2004-12-01 | CHIESI FARMACEUTICI S.p.A. | Novel lipid mixtures for synthetic surfactants |
| WO2008011559A2 (en) * | 2006-07-20 | 2008-01-24 | University Of Rochester | Synthetic lung surfactant and use thereof |
| EP1997502A1 (en) | 2007-06-01 | 2008-12-03 | CHIESI FARMACEUTICI S.p.A. | Reconstituted surfactants having improved properties |
| EP2022798A1 (en) | 2007-08-09 | 2009-02-11 | CHIESI FARMACEUTICI S.p.A. | Synthetic pulmonary surfactant peptides |
-
2007
- 2007-09-28 CN CN201310053516.8A patent/CN103169947B/zh active Active
- 2007-09-28 MX MX2009003638A patent/MX343064B/es active IP Right Grant
- 2007-09-28 UA UAA200903082A patent/UA94477C2/ru unknown
- 2007-09-28 HR HRP20140052TT patent/HRP20140052T1/hr unknown
- 2007-09-28 SI SI200731393T patent/SI2078038T1/sl unknown
- 2007-09-28 GE GEAP200711224A patent/GEP20125531B/en unknown
- 2007-09-28 ME MEP-2016-20A patent/ME02326B/me unknown
- 2007-09-28 JP JP2009531932A patent/JP5405307B2/ja active Active
- 2007-09-28 KR KR1020097007008A patent/KR101328851B1/ko active Active
- 2007-09-28 NZ NZ576189A patent/NZ576189A/en unknown
- 2007-09-28 ES ES07825212.9T patent/ES2438727T3/es active Active
- 2007-09-28 PT PT78252129T patent/PT2078038E/pt unknown
- 2007-09-28 WO PCT/IB2007/002841 patent/WO2008044109A1/en not_active Ceased
- 2007-09-28 RS RS20140037A patent/RS53172B/sr unknown
- 2007-09-28 EP EP07825212.9A patent/EP2078038B1/en active Active
- 2007-09-28 ME MEP-121/09A patent/MEP12109A/xx unknown
- 2007-09-28 EA EA200900373A patent/EA015802B1/ru unknown
- 2007-09-28 BR BRPI0715317-1A patent/BRPI0715317B1/pt active IP Right Grant
- 2007-09-28 MY MYPI20091454A patent/MY148127A/en unknown
- 2007-09-28 CA CA2666344A patent/CA2666344C/en active Active
- 2007-09-28 ZA ZA200902481A patent/ZA200902481B/xx unknown
- 2007-09-28 CN CN2007800382767A patent/CN101522711B/zh active Active
- 2007-09-28 AU AU2007306075A patent/AU2007306075B2/en active Active
- 2007-09-28 DK DK07825212.9T patent/DK2078038T3/da active
- 2007-09-28 PL PL07825212T patent/PL2078038T3/pl unknown
- 2007-10-11 AR ARP070104520A patent/AR063263A1/es not_active Application Discontinuation
- 2007-10-11 JO JO2007436A patent/JO2963B1/en active
- 2007-10-11 CL CL200702931A patent/CL2007002931A1/es unknown
- 2007-10-11 PE PE2007001375A patent/PE20081184A1/es active IP Right Grant
- 2007-10-11 TW TW096137965A patent/TWI388333B/zh active
-
2009
- 2009-03-25 TN TN2009000099A patent/TN2009000099A1/fr unknown
- 2009-04-07 IL IL198075A patent/IL198075A/en active IP Right Grant
- 2009-04-08 CO CO09036247A patent/CO6400235A2/es not_active Application Discontinuation
- 2009-04-13 US US12/422,581 patent/US8183210B2/en active Active
- 2009-04-14 NO NO20091441A patent/NO342038B1/no unknown
- 2009-05-08 MA MA31854A patent/MA31062B1/fr unknown
-
2012
- 2012-04-10 US US13/443,164 patent/US9238058B2/en active Active
-
2013
- 2013-08-02 JP JP2013161238A patent/JP2013241449A/ja active Pending
- 2013-12-11 CY CY20131101121T patent/CY1114716T1/el unknown
-
2018
- 2018-11-05 AR ARP180103211A patent/AR113422A2/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2846789T3 (es) | Composiciones que contienen complejos HC-HA/PTX3 y métodos de uso de los mismos | |
| TN2009000099A1 (en) | Reconstituted surfactants having improved properties | |
| MX2009012675A (es) | Tensioactivos reconstituidos que tienen propiedades mejoradas. | |
| MA33374B1 (fr) | Composition de surfactant reconstitué améliorée contenant des analogues de la protéine b du surfactant (sp-b) et de la protéine c du surfactant (sp-c) | |
| ATE242633T1 (de) | Dialkylfumarate zur behandlung von autoimmunerkrankungen | |
| WO1998033509A3 (en) | Useful properties of human lactoferrin and variants thereof | |
| DE60042215D1 (de) | Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit | |
| MA30041B1 (fr) | Immunoglobulines | |
| US6818621B2 (en) | Osteopontin-derived chemotactic and inhibitory agents and uses therefor | |
| WO2014168253A1 (ja) | 白血球の細胞外トラップ形成の阻害剤 | |
| ATE313562T1 (de) | Antimicrobielle wirkung des ersten kationischen cluster des menschlichen lactoferrins | |
| TW201004639A (en) | Treatment of rheumatoid arthritis with mammal beta defensins | |
| MA29625B1 (fr) | Immunoglobulines | |
| AU2017252344A1 (en) | Diagnosis of immune_activation using CLEVER-1, TNF-alpha and HLA-DR binding agents | |
| US20240041987A1 (en) | Novel bioactive peptide combinations and uses thereof | |
| JP2013530990A (ja) | 創傷治療に係るラクトフェリンの配列、組成物、及び方法 | |
| CA3155100A1 (en) | Il-15 fusion peptides used to treat cancer | |
| JP7863335B2 (ja) | 細胞外マトリックスに結合するＩＬ－１受容体アンタゴニスト（ＩＬ－１Ｒａ）融合タンパク質 | |
| CA3201966A1 (en) | Pre-treatment of msc with pparb/.delta. agonist for treatment of ischemia-reperfusion injury | |
| PT1317273E (pt) | Utilizacao de quimera il-6r/il-6 na doenca de huntington | |
| KR101169850B1 (ko) | 트로락스를 포함하는 골 대사성 질환 또는 골 전이성 암 질환 예방 및 치료용 약제학적 조성물 | |
| WO2002098454A3 (en) | Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools | |
| Samy et al. | Wound Healing Activity and Mechanisms of Action of an Antibacterial | |
| IL175019A0 (en) | Cxcl8 antagonists, their preparation and use | |
| BRPI0516935A (pt) | secretagogos de gh e usos dos mesmos |